Hepatitis B SIG Poster Highlights

Nov 09 2025
Convention Center: Science in the Park - Site A - Level 3
3:45 PM - 4:15 PM

World Class Speakers

Sarah Voytek, PhD
Presenter

Sarah Voytek, PhD
Gongxin He, PhD
Presenter

Gongxin He, PhD

Shanghai CureGene Pharmaceutical Co.
Tai-Chung Tseng, PhD
Presenter

Tai-Chung Tseng, PhD

National Taiwan University Hospital
Robert Gish, MD
Moderator

Robert Gish, MD

Robert G Gish Consultants LLC
Marc G. Ghany, MD, MHSc, FAASLD
Moderator

Marc G. Ghany, MD, MHSc, FAASLD

NIH/NIDDK

Description

Join us for a poster highlight of the top abstracts from the Hepatitis B/Delta (HBV/HDV) SIG. 
 

Journey Maps

Presentations

3:45 PM - 3:48 PM
Nov 09 2025
Washington, D.C.

Welcome & Introductions

Robert Gish, MD, Moderator
Hepatitis
3:48 PM - 3:53 PM
Nov 09 2025
Washington, D.C.

Preclinical pharmacology and safety of CRMA-1001, a novel epigenetic editor for chronic hepatitis B that demonstrates HBV surface antigen loss in animal models via precise HBV DNA methylation

Sarah Voytek, PhD, Presenter
Hepatitis
3:53 PM - 3:58 PM
Nov 09 2025
Washington, D.C.

A novel mRNA-based immunotherapy achieves complete elimination of human hepatitis B virus in chronic HBV mouse models

Gongxin He, PhD, Presenter
Hepatitis
3:58 PM - 4:03 PM
Nov 09 2025
Washington, D.C.

Hepatitis B Surface Antigen Level Identifies Inactive Chronic Hepatitis B Patients with HCC Risk Below Surveillance Threshold

Tai-Chung Tseng, PhD, Presenter
Hepatitis
4:03 PM - 4:15 PM
Nov 09 2025
Washington, D.C.

Q&A/Panel Discussion/Closing

Marc G. Ghany, MD, MHSc, FAASLD, Moderator
Hepatitis